======= PRDM11 ======= == Gene Information == * **Official Symbol**: PRDM11 * **Official Name**: PR/SET domain 11 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=56981|56981]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NQV5|Q9NQV5]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PRDM11&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PRDM11|Open PubMed]] * **OMIM**: [[https://omim.org/entry/616347|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: May be involved in transcription regulation. {ECO:0000269|PubMed:25499759}. No Pfam Domain information is available for this gene. |positive regulation of fibroblast apoptotic process| |core promoter binding| |regulation of fibroblast apoptotic process| |methyltransferase activity| |chromatin DNA binding| |negative regulation of cell growth| |negative regulation of growth| |methylation| |RNA polymerase II regulatory region sequence-specific DNA binding| |chromatin binding| |regulation of cell growth| |sequence-specific DNA binding| |positive regulation of apoptotic process| |positive regulation of programmed cell death| |regulation of growth| |DNA-binding transcription factor activity| |positive regulation of cell death| |regulation of MAPK cascade| |regulation of cell cycle| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |regulation of protein phosphorylation| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |positive regulation of transcription, DNA-templated| |regulation of apoptotic process| |negative regulation of biosynthetic process| |regulation of programmed cell death| |regulation of phosphorylation| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |regulation of cell death| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of intracellular signal transduction| |regulation of protein modification process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp532|TIC10 10μM R08 exp532]]|-1.88| |[[:results:exp101|Nicotinamide 1000μM R03 exp101]]|-1.73| |[[:results:exp420|Tunicamycin 0.04 to 0.125μM on day4 R07 exp420]]|1.81| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 10204 * **Expression level (log2 read counts)**: 2.86 {{:chemogenomics:nalm6 dist.png?nolink |}}